ChristianaCare and Lisen Imprinting Diagnostics Partner to Advance Lung Cancer Diagnosis

ChristianaCare and Lisen Imprinting Diagnostics have formed a research partnership. The collaboration focuses on enhancing lung cancer diagnostic methods. Both organizations will share expertise in clinical practice and molecular imprinting. The goal is to develop more accurate detection tools. Joint studies will be conducted to validate new approaches. Findings are intended to inform future diagnostic protocols. Improved diagnosis could lead to earlier treatment for patients. The initiative underscores a commitment to advancing oncology care.